Entertainment Novo Nordisk shares dive after heart medicine fails trial, dealing another blow toits pipeline July 31, 2026 gopalkumarthakur@gmail.com The experimental medicine ziltivekimab didn’t translate into a statistically meaningful reduction in major cardiovascular adverse events, Novo said Friday. Related posts: Chitrangda Singh on age-appropriate casting in Bollywood: “Everyone is trying to maintain their looks” Amaal Mallik on completing 12 years as an influential music voice, “The best melodies are yet to come” White House to pay TotalEnergies $1 billion to kill off East Coast wind farm projects Novo Nordisk rolls out Wegovy pill in the UAE — testing global appetite outside the U.S.
